$298M Revs; est. $285.9M
$106M AEBITDA; est. $83.1M
$174M GP; est. $152M
$46MM OI; est. $35.9M
58% GM; est. 53.2%
($23.1M) NI; est. ($22.1M)
"With strong performance in our core business and several meaningful catalysts on the horizon, the outlook has never been brighter. The team has done a phenomenal job carrying forward the momentum from last year, driving further improvements in production and retail. Given our financial performance and significant scale in key markets, Trulieve is best positioned for the wave of growth catalysts." Kim Rivers, CEO.
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.